Category: Regulatory

SK Life Science Posts Refund Notice; Dr. Reddy’s and Pfizer Issue NDC Changes

July 18, 2024 Bella Czajkowski, National Correspondent Views

Amgen announced a change to the national drug code for its osteoporosis drug, Prolia.

SK Life Science issued a refund notice for an epilepsy drug following a 340B price ceiling recalculation. Multiple drug manufacturers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HRSA Allows for Immediate 340B Enrollment in Texas Due to Hurricane; Hawaii Remains Eligible

July 18, 2024 William Newton, Associate Editor/Senior Writer Views

Due to Hurricane Beryl, certain Texas providers can immediately enroll in the 340B program without waiting for the normal registration period.

Eligible providers in Texas can now immediately enroll in the 340B program without waiting for the normal quarterly registration period [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GOP-Led House Appropriations Committee Votes to Cut HRSA Funding, Flat Funds OPA in Party Line Vote

July 16, 2024 Shannon Young, Associate Editor/Senior Writer Views

The House Appropriations Committee approved the Labor, Health and Human Services, Education and Related Agencies Appropriations Act on July 10.

The House panel responsible for federal appropriations legislation passed a bill last week that would cut funding for the Health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

CMS Proposes Rule to Exclude 340B Claims from Inflation Rebates; Reflects ‘Stronger Understanding’ of 340B than IRA Negotiation Guidance, Says Attorney

July 16, 2024 William Newton, Associate Editor/Senior Writer Views

CMS recently proposed a rule to fulfill its statutory obligation to exclude 340B claims from Medicare inflationary rebates.

The Centers for Medicare & Medicaid Services (CMS) has outlined how it plans to identify 340B claims to remove when [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drug Industry Takes Issue with IRA’s Drug Negotiation Guidance

July 11, 2024 Shannon Young, Associate Editor/Senior Writer Views

PhRMA recently urged CMS to establish a neutral clearinghouse and require accurate use of 340B claim modifiers to address nonduplication in its final guidance for Medicare drug price negotiations under the IRA.

Editor’s Note: In Tuesday’s issue, we looked at comments from 340B provider stakeholders, today we look more closely at the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Apotex to Issue Refunds to 340B Covered Entities

July 11, 2024 Shannon Young, Associate Editor/Senior Writer Views

Apotex Corp. announced in a July 2 notice to 340B providers that it will issue refunds to 340B covered entities that purchased any of nearly 400 products.

A Canadian drug manufacturer recently announced that it will refund covered entities for hundreds of different products purchased between 2021 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Providers Take Issue with CMS Draft Guidance on IRA Implementation Calling It “Problematic, Unworkable and Inconsistent”

July 9, 2024 Shannon Young, Associate Editor/Senior Writer Views

340B provider groups strongly criticized the Centers for Medicare & Medicaid Services’ draft guidance for Medicare drug price negotiations.

Editor’s Note: In today’s issue, we look at the 340B provider community’s comments to CMS. In a future issue, we [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Astellas Suspends its Contract Pharmacy Restrictions in More States; BMS and Sanofi Also Announce State Exemptions

July 9, 2024 Shannon Young, Associate Editor/Senior Writer Views

Astellas Pharma announced the suspension of its contract pharmacy policy in Maryland and Mississippi.

A Japanese drug manufacturer has ended its 340B contract pharmacy restrictions in Maryland and Mississippi in conjunction with new contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Coalition Conference Keynote: Program Faces ‘Progress Amid Challenges’

July 8, 2024 William Newton, Associate Editor/Senior Writer Views

Maureen Testoni, president and CEO of 340B Health, gave a keynote "state of 340B" address July 8 at the 340B Coalition summer conference.

The 340B program faces unprecedented challenges despite a series of states enacting 340B contract pharmacy access laws, the leader of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Supreme Court ‘Chevron’ Ruling Increases Pressure on Congress to Act on 340B But Unlikely to Immediately Impact Program Oversight

July 2, 2024 William Newton, Associate Editor/Senior Writer Views

Hospital groups are urging the Supreme Court to correct what they called HHS' misinterpretation of DSH percentage calculations.

A landmark Supreme Court decision to limit the broad regulatory authority of federal agencies will increase pressure for Congress to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live